➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Johnson and Johnson
Moodys
McKinsey
Express Scripts

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. ANCHEN PHARMACEUTICALS, INC. (D.N.J. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ASTRAZENECA AB v. ANCHEN PHARMACEUTICALS, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ASTRAZENECA AB v. ANCHEN PHARMACEUTICALS, INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-10-28 1 The Patents-In-Suit 11. United States Patent No. 6,926,907 (“the ’907 patent”), entitled…20 PageID: 7 patent, the ‘070 patent, and the ‘466 patent (collectively “the patents-in-suit”) by, inter… This is a civil action for patent infringement arising under the patent laws of the United States, …United States Patent and Trademark Office on August 9, 2005. The claims of the ’907 patent are directed…of the ’907 patent is attached as Exhibit A. 12. Pozen owns the ’907 patent by assignment External link to document
2011-12-12 15 Factual Background l0. United States Patent No. 6,926,907 (“the ‘907 patent”), entitled “Pharrnaceutical Compositions… 6,926,907 (“the ‘907 patent”) is attached to the Coniplaint as Exhibit A, and that Exhibit A speaks for… The Patents-In-Suit l l. Anchen admits that What appears to be a copy of United States Patent No. 6,926,907…appears to be a copy of United States Patent No. 6,369,085 (“the ‘085 patent”) is attached to the Complaint …appears to be a copy of United States Patent No. 7,411,070 (“the ‘070 patent”) is attached to the Complaint External link to document
2012-01-19 28 only, over the asserted claims of U.S. Patent Nos. 6,926,907 1 By Stipulated Consent Order (D.… of the ‘907 patent, the ‘085 patent, the ‘070 patent, and the ‘466 patent (the “patents-in-suit”). …188 (the “’907 patent”); 6,369,085 (the “’085 patent”); 7,411,070 (the “’070 patent”); and 7,745,466…contend the patents-in-suit are valid. Plaintiffs admit that Anchen contends the patents-in-suit are … purports to state a cause of action under the patent laws of the United States, 35 U.S.C.§ 1 et seq. External link to document
2012-01-31 29 Factual Background 10. United States Patent No. 6,926,907 (“the ‘907 patent”), entitled “Pharmaceutical Compositions… The Patents-In~Suit 11. Anchen admits that What appears to be a copy of United States Patent No. 6,…appears to be a copy of United States Patent No. 6,369,085 (“the ‘085 patent”) is attached to the Complaint …appears to be a copy of United States Patent No. 7,411,070 (“the ‘070 patent”) is attached to the Complaint …appears to be a copy of United States Patent No. 7,745,466 (“the ‘466 patent) is attached to the Complaint as External link to document
2012-02-14 31 only, over the asserted claims of U.S. Patent Nos. 6,926,907 1 By Stipulated Consent Order (D.… of the ‘907 patent, the ‘085 patent, the ‘070 patent, and the ‘466 patent (the “patents-in-suit”). …218 (the “’907 patent”); 6,369,085 (the “’085 patent”); 7,411,070 (the “’070 patent”); and 7,745,466…contend the patents-in-suit are valid. Plaintiffs admit that Anchen contends the patents-in-suit are … purports to state a cause of action under the patent laws of the United States, 35 U.S.C.§ 1 et seq. External link to document
2014-06-11 64 these patents: U.S. Patent Nos. 5,900,424 (“the ’424 patent”); 6,369,085 (“the ’085 patent”); 6,926,907… (“the ’907 patent”); 7,411,070 (“the ’070 patent”); and 7,745,466 (“the ’466 patent”). Defendant …any patent that claims the drug, or a method of using the drug, and for which a claim of patent infringement…wishing to challenge the validity of a patent or to claim that the patent would not be infringed by the …drug claimed in a patent or the use of which is claimed in a patent … if the purpose of such External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Mallinckrodt
AstraZeneca
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.